Cardiomyopathy associated with iron overload: How does iron enter myocytes and what are the implications for pharmacological therapy?
© 2015 Informa Healthcare USA, Inc. Iron overload cardiomyopathy is one of the most common causes of death in thalassemia patients. Although new iron chelating agents have been developed, the mortality rate from heart failure remains elevated as a result of iron overload. This could be due to the fa...
Saved in:
Main Authors: | Wijarnpreecha,K., Kumfu,S., Chattipakorn,S.C., Chattipakorn,N. |
---|---|
Format: | Review |
Published: |
Informa Healthcare
2015
|
Subjects: | |
Online Access: | http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84921923611&origin=inward http://cmuir.cmu.ac.th/handle/6653943832/38372 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Cardiomyopathy associated with iron overload: How does iron enter myocytes and what are the implications for pharmacological therapy?
by: Wijarnpreecha,K., et al.
Published: (2015) -
Roles of lipocalin 2 and adiponectin in iron overload cardiomyopathy
by: Natthaphat Siri-Angkul, et al.
Published: (2018) -
The correlation of α-globin gene mutations and the XmnI polymorphism with clinical severity of Hb E/β-thalassemia
by: Charoenkwan,P., et al.
Published: (2015) -
A novel test tube method of screening for hemoglobin E
by: Tatu,T., et al.
Published: (2015) -
Quantification of hemoglobin Constant Spring in heterozygote and homozygote by a capillary electrophoresis method
by: Pornprasert,S., et al.
Published: (2015)